Literature DB >> 9824348

Are relatives of patients with multiple HNPCC spectrum tumours at increased risk of cancer?

S R Brown1, P J Finan, D T Bishop.   

Abstract

BACKGROUND: Relatives of patients with early onset colorectal cancer, a feature of hereditary non-polyposis colorectal cancer (HNPCC), are at increased risk of colorectal cancer. AIMS: To investigate risk in relatives of patients with multiple primary cancers, another feature of HNPCC.
METHODS: Details were obtained on patients from one region who had developed colorectal cancer and a separate primary from the HNPCC tumour spectrum (colorectal, stomach, urinary, ovary, endometrial). Overall, 157 patients had second primaries occurring between 1990 and 1995 and 128 completed family histories were obtained by structured interview (study group). A comparison group of 444 patients with a single colorectal cancer were similarly interviewed.
RESULTS: Fifteen families (13%) from the study group were suggestive of HNPCC compared with three (0.7%, p<0.0001) from the comparison group. Overall risk of colorectal cancer in close relatives of the study group was 3.4 times the general population rate compared with 1.8 times for the comparison group. Bowel cancer risk was even higher for relatives of bowel/ovary and bowel/endometrial subgroups, but was similar to the comparison group for the bowel/bowel subgroup. Finally, extracolonic HNPCC associated cancers were seen twice as frequently as expected in the general population in relatives of the study group.
CONCLUSION: This study highlights the importance of taking a family history in patients with multiple primary cancers and indicates the risk of malignancy in their relatives.

Entities:  

Mesh:

Year:  1998        PMID: 9824348      PMCID: PMC1727311          DOI: 10.1136/gut.43.5.664

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

Review 1.  The genetics of colorectal cancer.

Authors:  D T Bishop; H J Thomas
Journal:  Cancer Surv       Date:  1990

2.  Family studies in cancer of the colon and rectum.

Authors:  E Lovett
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

3.  Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic.

Authors:  R S Houlston; V Murday; C Harocopos; C B Williams; J Slack
Journal:  BMJ       Date:  1990 Aug 18-25

Review 4.  Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review.

Authors:  H T Lynch; T Smyrk
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

5.  Frequency of familial colorectal cancer.

Authors:  B M Stephenson; P J Finan; J Gascoyne; F Garbett; V A Murday; D T Bishop
Journal:  Br J Surg       Date:  1991-10       Impact factor: 6.939

6.  Extracolonic cancer in hereditary nonpolyposis colorectal cancer.

Authors:  P Watson; H T Lynch
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

7.  Cancer risk in relatives of patients with common colorectal cancer.

Authors:  D J St John; F T McDermott; J L Hopper; E A Debney; W R Johnson; E S Hughes
Journal:  Ann Intern Med       Date:  1993-05-15       Impact factor: 25.391

8.  Metachronous colorectal cancer in young patients: expression of the hereditary nonpolyposis colorectal cancer syndrome?

Authors:  L B Svendsen; S Bülow; A Mellemgaard
Journal:  Dis Colon Rectum       Date:  1991-09       Impact factor: 4.585

9.  Segregation analysis of hereditary nonpolyposis colorectal cancer.

Authors:  J E Bailey-Wilson; R C Elston; G S Schuelke; W Kimberling; W Albano; J F Lynch; H T Lynch
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

10.  Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry.

Authors:  M Ponz de Leon; R Sassatelli; C Sacchetti; G Zanghieri; A Scalmati; L Roncucci
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

View more
  2 in total

1.  [Strategies for genetic counseling and examination of families with hereditary tumor diseases].

Authors:  E Gödde
Journal:  Med Klin (Munich)       Date:  1999-10-15

2.  Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency.

Authors:  F V N Din; L A Stark; M G Dunlop
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.